Global CAR T-Cell-Based Drug Market Growth (Status and Outlook) 2026-2032
The global CAR T-Cell-Based Drug market size is predicted to grow from US$ 6394 million in 2025 to US$ 39930 million in 2032; it is expected to grow at a CAGR of 30.5% from 2026 to 2032.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient's T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
LPI (LP Information)' newest research report, the ?CAR T-Cell-Based Drug Industry Forecast? looks at past sales and reviews total world CAR T-Cell-Based Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR T-Cell-Based Drug sales for 2026 through 2032. With CAR T-Cell-Based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR T-Cell-Based Drug industry.
This Insight Report provides a comprehensive analysis of the global CAR T-Cell-Based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR T-Cell-Based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CAR T-Cell-Based Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR T-Cell-Based Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR T-Cell-Based Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-Cell-Based Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The CAR T-cell-based drug market is driven by the growing demand for innovative and targeted cancer therapies. Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary approach that involves genetically modifying a patient's T cells to recognize and attack cancer cells. The success of CAR T-cell therapies in treating certain types of blood cancers, such as leukemia and lymphoma, has fueled market growth and encouraged research into expanding the application of CAR T-cell therapy to other solid tumor malignancies. However, the market also faces challenges, including the high cost of CAR T-cell therapy and the complexity of the manufacturing process, which may limit patient access. Additionally, the potential for severe side effects and the need for patient selection and management pose regulatory and clinical challenges. To succeed, companies must focus on advancing research, streamlining the production process, collaborating with healthcare providers to improve patient access and support, and addressing safety and efficacy concerns to establish CAR T-cell-based drugs as a transformative treatment option for cancer patients.
LPI (LP Information)' newest research report, the ?CAR T-Cell-Based Drug Industry Forecast? looks at past sales and reviews total world CAR T-Cell-Based Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR T-Cell-Based Drug sales for 2026 through 2032. With CAR T-Cell-Based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR T-Cell-Based Drug industry.
This Insight Report provides a comprehensive analysis of the global CAR T-Cell-Based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR T-Cell-Based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global CAR T-Cell-Based Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR T-Cell-Based Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR T-Cell-Based Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-Cell-Based Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CD19-targeted
- BCMA-targeted
- Lymphoma
- Multiple Myeloma
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
- CARsgen Therapeutics
- Autolus Therapeutics
- Sorrento Therapeutics
- Mustang Bio
- Bluebird Bio
- Cellectis
- Allogene Therapeutics
- Celyad
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell-Based Drug Market Size (2021-2032)
2.1.2 CAR T-Cell-Based Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR T-Cell-Based Drug by Country/Region (2021, 2025 & 2032)
2.2 CAR T-Cell-Based Drug Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.2.3 CAR T-Cell-Based Drug Market Size by Type
2.2.3.1 CAR T-Cell-Based Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
2.3 CAR T-Cell-Based Drug Segment by Application
2.3.1 Lymphoma
2.3.2 Multiple Myeloma
2.3.3 CAR T-Cell-Based Drug Market Size by Application
2.3.3.1 CAR T-Cell-Based Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
3 CAR T-CELL-BASED DRUG MARKET SIZE BY PLAYER
3.1 CAR T-Cell-Based Drug Market Size Market Share by Player
3.1.1 Global CAR T-Cell-Based Drug Revenue by Player (2021-2026)
3.1.2 Global CAR T-Cell-Based Drug Revenue Market Share by Player (2021-2026)
3.2 Global CAR T-Cell-Based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL-BASED DRUG BY REGION
4.1 CAR T-Cell-Based Drug Market Size by Region (2021-2026)
4.2 Global CAR T-Cell-Based Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR T-Cell-Based Drug Market Size Growth (2021-2026)
4.4 APAC CAR T-Cell-Based Drug Market Size Growth (2021-2026)
4.5 Europe CAR T-Cell-Based Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR T-Cell-Based Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR T-Cell-Based Drug Market Size by Country (2021-2026)
5.2 Americas CAR T-Cell-Based Drug Market Size by Type (2021-2026)
5.3 Americas CAR T-Cell-Based Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell-Based Drug Market Size by Region (2021-2026)
6.2 APAC CAR T-Cell-Based Drug Market Size by Type (2021-2026)
6.3 APAC CAR T-Cell-Based Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell-Based Drug Market Size by Country (2021-2026)
7.2 Europe CAR T-Cell-Based Drug Market Size by Type (2021-2026)
7.3 Europe CAR T-Cell-Based Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell-Based Drug by Region (2021-2026)
8.2 Middle East & Africa CAR T-Cell-Based Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR T-Cell-Based Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL-BASED DRUG MARKET FORECAST
10.1 Global CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.1.1 Global CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.1.2 Americas CAR T-Cell-Based Drug Forecast
10.1.3 APAC CAR T-Cell-Based Drug Forecast
10.1.4 Europe CAR T-Cell-Based Drug Forecast
10.1.5 Middle East & Africa CAR T-Cell-Based Drug Forecast
10.2 Americas CAR T-Cell-Based Drug Forecast by Country (2027-2032)
10.2.1 United States Market CAR T-Cell-Based Drug Forecast
10.2.2 Canada Market CAR T-Cell-Based Drug Forecast
10.2.3 Mexico Market CAR T-Cell-Based Drug Forecast
10.2.4 Brazil Market CAR T-Cell-Based Drug Forecast
10.3 APAC CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.3.1 China CAR T-Cell-Based Drug Market Forecast
10.3.2 Japan Market CAR T-Cell-Based Drug Forecast
10.3.3 Korea Market CAR T-Cell-Based Drug Forecast
10.3.4 Southeast Asia Market CAR T-Cell-Based Drug Forecast
10.3.5 India Market CAR T-Cell-Based Drug Forecast
10.3.6 Australia Market CAR T-Cell-Based Drug Forecast
10.4 Europe CAR T-Cell-Based Drug Forecast by Country (2027-2032)
10.4.1 Germany Market CAR T-Cell-Based Drug Forecast
10.4.2 France Market CAR T-Cell-Based Drug Forecast
10.4.3 UK Market CAR T-Cell-Based Drug Forecast
10.4.4 Italy Market CAR T-Cell-Based Drug Forecast
10.4.5 Russia Market CAR T-Cell-Based Drug Forecast
10.5 Middle East & Africa CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR T-Cell-Based Drug Forecast
10.5.2 South Africa Market CAR T-Cell-Based Drug Forecast
10.5.3 Israel Market CAR T-Cell-Based Drug Forecast
10.5.4 Turkey Market CAR T-Cell-Based Drug Forecast
10.6 Global CAR T-Cell-Based Drug Forecast by Type (2027-2032)
10.7 Global CAR T-Cell-Based Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR T-Cell-Based Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-Cell-Based Drug Product Offered
11.1.3 Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-Cell-Based Drug Product Offered
11.2.3 Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Offered
11.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-Cell-Based Drug Product Offered
11.4.3 J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-Cell-Based Drug Product Offered
11.5.3 JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-Cell-Based Drug Product Offered
11.6.3 FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Information
11.7.2 CARsgen Therapeutics CAR T-Cell-Based Drug Product Offered
11.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CARsgen Therapeutics Main Business Overview
11.7.5 CARsgen Therapeutics Latest Developments
11.8 Autolus Therapeutics
11.8.1 Autolus Therapeutics Company Information
11.8.2 Autolus Therapeutics CAR T-Cell-Based Drug Product Offered
11.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Autolus Therapeutics Main Business Overview
11.8.5 Autolus Therapeutics Latest Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics CAR T-Cell-Based Drug Product Offered
11.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sorrento Therapeutics Main Business Overview
11.9.5 Sorrento Therapeutics Latest Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Information
11.10.2 Mustang Bio CAR T-Cell-Based Drug Product Offered
11.10.3 Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Mustang Bio Main Business Overview
11.10.5 Mustang Bio Latest Developments
11.11 Bluebird Bio
11.11.1 Bluebird Bio Company Information
11.11.2 Bluebird Bio CAR T-Cell-Based Drug Product Offered
11.11.3 Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bluebird Bio Main Business Overview
11.11.5 Bluebird Bio Latest Developments
11.12 Cellectis
11.12.1 Cellectis Company Information
11.12.2 Cellectis CAR T-Cell-Based Drug Product Offered
11.12.3 Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cellectis Main Business Overview
11.12.5 Cellectis Latest Developments
11.13 Allogene Therapeutics
11.13.1 Allogene Therapeutics Company Information
11.13.2 Allogene Therapeutics CAR T-Cell-Based Drug Product Offered
11.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Allogene Therapeutics Main Business Overview
11.13.5 Allogene Therapeutics Latest Developments
11.14 Celyad
11.14.1 Celyad Company Information
11.14.2 Celyad CAR T-Cell-Based Drug Product Offered
11.14.3 Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Celyad Main Business Overview
11.14.5 Celyad Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR T-Cell-Based Drug Market Size (2021-2032)
2.1.2 CAR T-Cell-Based Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR T-Cell-Based Drug by Country/Region (2021, 2025 & 2032)
2.2 CAR T-Cell-Based Drug Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.2.3 CAR T-Cell-Based Drug Market Size by Type
2.2.3.1 CAR T-Cell-Based Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
2.3 CAR T-Cell-Based Drug Segment by Application
2.3.1 Lymphoma
2.3.2 Multiple Myeloma
2.3.3 CAR T-Cell-Based Drug Market Size by Application
2.3.3.1 CAR T-Cell-Based Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
3 CAR T-CELL-BASED DRUG MARKET SIZE BY PLAYER
3.1 CAR T-Cell-Based Drug Market Size Market Share by Player
3.1.1 Global CAR T-Cell-Based Drug Revenue by Player (2021-2026)
3.1.2 Global CAR T-Cell-Based Drug Revenue Market Share by Player (2021-2026)
3.2 Global CAR T-Cell-Based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-CELL-BASED DRUG BY REGION
4.1 CAR T-Cell-Based Drug Market Size by Region (2021-2026)
4.2 Global CAR T-Cell-Based Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR T-Cell-Based Drug Market Size Growth (2021-2026)
4.4 APAC CAR T-Cell-Based Drug Market Size Growth (2021-2026)
4.5 Europe CAR T-Cell-Based Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR T-Cell-Based Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR T-Cell-Based Drug Market Size by Country (2021-2026)
5.2 Americas CAR T-Cell-Based Drug Market Size by Type (2021-2026)
5.3 Americas CAR T-Cell-Based Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-Cell-Based Drug Market Size by Region (2021-2026)
6.2 APAC CAR T-Cell-Based Drug Market Size by Type (2021-2026)
6.3 APAC CAR T-Cell-Based Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR T-Cell-Based Drug Market Size by Country (2021-2026)
7.2 Europe CAR T-Cell-Based Drug Market Size by Type (2021-2026)
7.3 Europe CAR T-Cell-Based Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR T-Cell-Based Drug by Region (2021-2026)
8.2 Middle East & Africa CAR T-Cell-Based Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR T-Cell-Based Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR T-CELL-BASED DRUG MARKET FORECAST
10.1 Global CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.1.1 Global CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.1.2 Americas CAR T-Cell-Based Drug Forecast
10.1.3 APAC CAR T-Cell-Based Drug Forecast
10.1.4 Europe CAR T-Cell-Based Drug Forecast
10.1.5 Middle East & Africa CAR T-Cell-Based Drug Forecast
10.2 Americas CAR T-Cell-Based Drug Forecast by Country (2027-2032)
10.2.1 United States Market CAR T-Cell-Based Drug Forecast
10.2.2 Canada Market CAR T-Cell-Based Drug Forecast
10.2.3 Mexico Market CAR T-Cell-Based Drug Forecast
10.2.4 Brazil Market CAR T-Cell-Based Drug Forecast
10.3 APAC CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.3.1 China CAR T-Cell-Based Drug Market Forecast
10.3.2 Japan Market CAR T-Cell-Based Drug Forecast
10.3.3 Korea Market CAR T-Cell-Based Drug Forecast
10.3.4 Southeast Asia Market CAR T-Cell-Based Drug Forecast
10.3.5 India Market CAR T-Cell-Based Drug Forecast
10.3.6 Australia Market CAR T-Cell-Based Drug Forecast
10.4 Europe CAR T-Cell-Based Drug Forecast by Country (2027-2032)
10.4.1 Germany Market CAR T-Cell-Based Drug Forecast
10.4.2 France Market CAR T-Cell-Based Drug Forecast
10.4.3 UK Market CAR T-Cell-Based Drug Forecast
10.4.4 Italy Market CAR T-Cell-Based Drug Forecast
10.4.5 Russia Market CAR T-Cell-Based Drug Forecast
10.5 Middle East & Africa CAR T-Cell-Based Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR T-Cell-Based Drug Forecast
10.5.2 South Africa Market CAR T-Cell-Based Drug Forecast
10.5.3 Israel Market CAR T-Cell-Based Drug Forecast
10.5.4 Turkey Market CAR T-Cell-Based Drug Forecast
10.6 Global CAR T-Cell-Based Drug Forecast by Type (2027-2032)
10.7 Global CAR T-Cell-Based Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR T-Cell-Based Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-Cell-Based Drug Product Offered
11.1.3 Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-Cell-Based Drug Product Offered
11.2.3 Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Offered
11.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-Cell-Based Drug Product Offered
11.4.3 J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-Cell-Based Drug Product Offered
11.5.3 JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-Cell-Based Drug Product Offered
11.6.3 FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Information
11.7.2 CARsgen Therapeutics CAR T-Cell-Based Drug Product Offered
11.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 CARsgen Therapeutics Main Business Overview
11.7.5 CARsgen Therapeutics Latest Developments
11.8 Autolus Therapeutics
11.8.1 Autolus Therapeutics Company Information
11.8.2 Autolus Therapeutics CAR T-Cell-Based Drug Product Offered
11.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Autolus Therapeutics Main Business Overview
11.8.5 Autolus Therapeutics Latest Developments
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Information
11.9.2 Sorrento Therapeutics CAR T-Cell-Based Drug Product Offered
11.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sorrento Therapeutics Main Business Overview
11.9.5 Sorrento Therapeutics Latest Developments
11.10 Mustang Bio
11.10.1 Mustang Bio Company Information
11.10.2 Mustang Bio CAR T-Cell-Based Drug Product Offered
11.10.3 Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Mustang Bio Main Business Overview
11.10.5 Mustang Bio Latest Developments
11.11 Bluebird Bio
11.11.1 Bluebird Bio Company Information
11.11.2 Bluebird Bio CAR T-Cell-Based Drug Product Offered
11.11.3 Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bluebird Bio Main Business Overview
11.11.5 Bluebird Bio Latest Developments
11.12 Cellectis
11.12.1 Cellectis Company Information
11.12.2 Cellectis CAR T-Cell-Based Drug Product Offered
11.12.3 Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cellectis Main Business Overview
11.12.5 Cellectis Latest Developments
11.13 Allogene Therapeutics
11.13.1 Allogene Therapeutics Company Information
11.13.2 Allogene Therapeutics CAR T-Cell-Based Drug Product Offered
11.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Allogene Therapeutics Main Business Overview
11.13.5 Allogene Therapeutics Latest Developments
11.14 Celyad
11.14.1 Celyad Company Information
11.14.2 Celyad CAR T-Cell-Based Drug Product Offered
11.14.3 Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Celyad Main Business Overview
11.14.5 Celyad Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR T-Cell-Based Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR T-Cell-Based Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CD19-targeted
Table 4. Major Players of BCMA-targeted
Table 5. CAR T-Cell-Based Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Table 8. CAR T-Cell-Based Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Table 11. Global CAR T-Cell-Based Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global CAR T-Cell-Based Drug Revenue Market Share by Player (2021-2026)
Table 13. CAR T-Cell-Based Drug Key Players Head office and Products Offered
Table 14. CAR T-Cell-Based Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CAR T-Cell-Based Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Table 19. Global CAR T-Cell-Based Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global CAR T-Cell-Based Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas CAR T-Cell-Based Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas CAR T-Cell-Based Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC CAR T-Cell-Based Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe CAR T-Cell-Based Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe CAR T-Cell-Based Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa CAR T-Cell-Based Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CAR T-Cell-Based Drug
Table 39. Key Market Challenges & Risks of CAR T-Cell-Based Drug
Table 40. Key Industry Trends of CAR T-Cell-Based Drug
Table 41. Global CAR T-Cell-Based Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global CAR T-Cell-Based Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global CAR T-Cell-Based Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global CAR T-Cell-Based Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Novartis Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 46. Novartis CAR T-Cell-Based Drug Product Offered
Table 47. Novartis CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Gilead Sciences Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 51. Gilead Sciences CAR T-Cell-Based Drug Product Offered
Table 52. Gilead Sciences CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gilead Sciences Main Business
Table 54. Gilead Sciences Latest Developments
Table 55. Bristol-Myers Squibb Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 56. Bristol-Myers Squibb CAR T-Cell-Based Drug Product Offered
Table 57. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. J & J Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 61. J & J CAR T-Cell-Based Drug Product Offered
Table 62. J & J CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. J & J Main Business
Table 64. J & J Latest Developments
Table 65. JW Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 66. JW Therapeutics CAR T-Cell-Based Drug Product Offered
Table 67. JW Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. JW Therapeutics Main Business
Table 69. JW Therapeutics Latest Developments
Table 70. FOSUNKite Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 71. FOSUNKite CAR T-Cell-Based Drug Product Offered
Table 72. FOSUNKite CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. FOSUNKite Main Business
Table 74. FOSUNKite Latest Developments
Table 75. CARsgen Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 76. CARsgen Therapeutics CAR T-Cell-Based Drug Product Offered
Table 77. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. CARsgen Therapeutics Main Business
Table 79. CARsgen Therapeutics Latest Developments
Table 80. Autolus Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 81. Autolus Therapeutics CAR T-Cell-Based Drug Product Offered
Table 82. Autolus Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Autolus Therapeutics Main Business
Table 84. Autolus Therapeutics Latest Developments
Table 85. Sorrento Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 86. Sorrento Therapeutics CAR T-Cell-Based Drug Product Offered
Table 87. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Sorrento Therapeutics Main Business
Table 89. Sorrento Therapeutics Latest Developments
Table 90. Mustang Bio Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 91. Mustang Bio CAR T-Cell-Based Drug Product Offered
Table 92. Mustang Bio CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Mustang Bio Main Business
Table 94. Mustang Bio Latest Developments
Table 95. Bluebird Bio Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 96. Bluebird Bio CAR T-Cell-Based Drug Product Offered
Table 97. Bluebird Bio CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Bluebird Bio Main Business
Table 99. Bluebird Bio Latest Developments
Table 100. Cellectis Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 101. Cellectis CAR T-Cell-Based Drug Product Offered
Table 102. Cellectis CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Cellectis Main Business
Table 104. Cellectis Latest Developments
Table 105. Allogene Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 106. Allogene Therapeutics CAR T-Cell-Based Drug Product Offered
Table 107. Allogene Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Allogene Therapeutics Main Business
Table 109. Allogene Therapeutics Latest Developments
Table 110. Celyad Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 111. Celyad CAR T-Cell-Based Drug Product Offered
Table 112. Celyad CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Celyad Main Business
Table 114. Celyad Latest Developments
Table 1. CAR T-Cell-Based Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR T-Cell-Based Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of CD19-targeted
Table 4. Major Players of BCMA-targeted
Table 5. CAR T-Cell-Based Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Table 8. CAR T-Cell-Based Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Table 11. Global CAR T-Cell-Based Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global CAR T-Cell-Based Drug Revenue Market Share by Player (2021-2026)
Table 13. CAR T-Cell-Based Drug Key Players Head office and Products Offered
Table 14. CAR T-Cell-Based Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CAR T-Cell-Based Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Table 19. Global CAR T-Cell-Based Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global CAR T-Cell-Based Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas CAR T-Cell-Based Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas CAR T-Cell-Based Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC CAR T-Cell-Based Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe CAR T-Cell-Based Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe CAR T-Cell-Based Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa CAR T-Cell-Based Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa CAR T-Cell-Based Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa CAR T-Cell-Based Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CAR T-Cell-Based Drug
Table 39. Key Market Challenges & Risks of CAR T-Cell-Based Drug
Table 40. Key Industry Trends of CAR T-Cell-Based Drug
Table 41. Global CAR T-Cell-Based Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global CAR T-Cell-Based Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global CAR T-Cell-Based Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global CAR T-Cell-Based Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Novartis Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 46. Novartis CAR T-Cell-Based Drug Product Offered
Table 47. Novartis CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Gilead Sciences Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 51. Gilead Sciences CAR T-Cell-Based Drug Product Offered
Table 52. Gilead Sciences CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Gilead Sciences Main Business
Table 54. Gilead Sciences Latest Developments
Table 55. Bristol-Myers Squibb Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 56. Bristol-Myers Squibb CAR T-Cell-Based Drug Product Offered
Table 57. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. J & J Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 61. J & J CAR T-Cell-Based Drug Product Offered
Table 62. J & J CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. J & J Main Business
Table 64. J & J Latest Developments
Table 65. JW Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 66. JW Therapeutics CAR T-Cell-Based Drug Product Offered
Table 67. JW Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. JW Therapeutics Main Business
Table 69. JW Therapeutics Latest Developments
Table 70. FOSUNKite Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 71. FOSUNKite CAR T-Cell-Based Drug Product Offered
Table 72. FOSUNKite CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. FOSUNKite Main Business
Table 74. FOSUNKite Latest Developments
Table 75. CARsgen Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 76. CARsgen Therapeutics CAR T-Cell-Based Drug Product Offered
Table 77. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. CARsgen Therapeutics Main Business
Table 79. CARsgen Therapeutics Latest Developments
Table 80. Autolus Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 81. Autolus Therapeutics CAR T-Cell-Based Drug Product Offered
Table 82. Autolus Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Autolus Therapeutics Main Business
Table 84. Autolus Therapeutics Latest Developments
Table 85. Sorrento Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 86. Sorrento Therapeutics CAR T-Cell-Based Drug Product Offered
Table 87. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Sorrento Therapeutics Main Business
Table 89. Sorrento Therapeutics Latest Developments
Table 90. Mustang Bio Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 91. Mustang Bio CAR T-Cell-Based Drug Product Offered
Table 92. Mustang Bio CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Mustang Bio Main Business
Table 94. Mustang Bio Latest Developments
Table 95. Bluebird Bio Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 96. Bluebird Bio CAR T-Cell-Based Drug Product Offered
Table 97. Bluebird Bio CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Bluebird Bio Main Business
Table 99. Bluebird Bio Latest Developments
Table 100. Cellectis Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 101. Cellectis CAR T-Cell-Based Drug Product Offered
Table 102. Cellectis CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Cellectis Main Business
Table 104. Cellectis Latest Developments
Table 105. Allogene Therapeutics Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 106. Allogene Therapeutics CAR T-Cell-Based Drug Product Offered
Table 107. Allogene Therapeutics CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Allogene Therapeutics Main Business
Table 109. Allogene Therapeutics Latest Developments
Table 110. Celyad Details, Company Type, CAR T-Cell-Based Drug Area Served and Its Competitors
Table 111. Celyad CAR T-Cell-Based Drug Product Offered
Table 112. Celyad CAR T-Cell-Based Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Celyad Main Business
Table 114. Celyad Latest Developments
LIST OF FIGURES
Figure 1. CAR T-Cell-Based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-Cell-Based Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR T-Cell-Based Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR T-Cell-Based Drug Sales Market Share by Country/Region (2025)
Figure 8. CAR T-Cell-Based Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR T-Cell-Based Drug Market Size Market Share by Type in 2025
Figure 10. CAR T-Cell-Based Drug in Lymphoma
Figure 11. Global CAR T-Cell-Based Drug Market: Lymphoma (2021-2026) & ($ millions)
Figure 12. CAR T-Cell-Based Drug in Multiple Myeloma
Figure 13. Global CAR T-Cell-Based Drug Market: Multiple Myeloma (2021-2026) & ($ millions)
Figure 14. Global CAR T-Cell-Based Drug Market Size Market Share by Application in 2025
Figure 15. Global CAR T-Cell-Based Drug Revenue Market Share by Player in 2025
Figure 16. Global CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Figure 17. Americas CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 18. APAC CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 19. Europe CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 21. Americas CAR T-Cell-Based Drug Value Market Share by Country in 2025
Figure 22. United States CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC CAR T-Cell-Based Drug Market Size Market Share by Region in 2025
Figure 27. APAC CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Figure 28. APAC CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Figure 29. China CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. India CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe CAR T-Cell-Based Drug Market Size Market Share by Country in 2025
Figure 36. Europe CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Figure 37. Europe CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Figure 38. Germany CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. France CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. UK CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Figure 46. Egypt CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 52. APAC CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 53. Europe CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 55. United States CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 56. Canada CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 57. Mexico CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 58. Brazil CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 59. China CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 60. Japan CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 61. Korea CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 63. India CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 64. Australia CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 65. Germany CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 66. France CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 67. UK CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 68. Italy CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 69. Russia CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 70. Egypt CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 71. South Africa CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 72. Israel CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 73. Turkey CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 74. Global CAR T-Cell-Based Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global CAR T-Cell-Based Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 1. CAR T-Cell-Based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-Cell-Based Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR T-Cell-Based Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR T-Cell-Based Drug Sales Market Share by Country/Region (2025)
Figure 8. CAR T-Cell-Based Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR T-Cell-Based Drug Market Size Market Share by Type in 2025
Figure 10. CAR T-Cell-Based Drug in Lymphoma
Figure 11. Global CAR T-Cell-Based Drug Market: Lymphoma (2021-2026) & ($ millions)
Figure 12. CAR T-Cell-Based Drug in Multiple Myeloma
Figure 13. Global CAR T-Cell-Based Drug Market: Multiple Myeloma (2021-2026) & ($ millions)
Figure 14. Global CAR T-Cell-Based Drug Market Size Market Share by Application in 2025
Figure 15. Global CAR T-Cell-Based Drug Revenue Market Share by Player in 2025
Figure 16. Global CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Figure 17. Americas CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 18. APAC CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 19. Europe CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa CAR T-Cell-Based Drug Market Size 2021-2026 ($ millions)
Figure 21. Americas CAR T-Cell-Based Drug Value Market Share by Country in 2025
Figure 22. United States CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC CAR T-Cell-Based Drug Market Size Market Share by Region in 2025
Figure 27. APAC CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Figure 28. APAC CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Figure 29. China CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. India CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe CAR T-Cell-Based Drug Market Size Market Share by Country in 2025
Figure 36. Europe CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Figure 37. Europe CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Figure 38. Germany CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. France CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. UK CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa CAR T-Cell-Based Drug Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa CAR T-Cell-Based Drug Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa CAR T-Cell-Based Drug Market Size Market Share by Application (2021-2026)
Figure 46. Egypt CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries CAR T-Cell-Based Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 52. APAC CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 53. Europe CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 55. United States CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 56. Canada CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 57. Mexico CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 58. Brazil CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 59. China CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 60. Japan CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 61. Korea CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 63. India CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 64. Australia CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 65. Germany CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 66. France CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 67. UK CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 68. Italy CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 69. Russia CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 70. Egypt CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 71. South Africa CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 72. Israel CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 73. Turkey CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
Figure 74. Global CAR T-Cell-Based Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global CAR T-Cell-Based Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries CAR T-Cell-Based Drug Market Size 2027-2032 ($ millions)
